{{Infobox disease
 | Name           = Amaurosis fugax
 | Image          = Gray873.png
 | Caption        = The arteries of the choroid and iris. The greater part of the sclera has been removed.
 | DiseasesDB     = 501
 | ICD10          = {{ICD10|G|45|3|g|40}}
 | ICD9           = {{ICD9|362.34}}
 | ICDO           = 
 | OMIM           = 
 | MedlinePlus    = 000784
 | eMedicineSubj  = neuro |
 | eMedicineTopic = 480 |
 | MeshID         = D020757
}}

'''Amaurosis fugax''' (Latin ''fugax'' meaning ''fleeting'', Greek ''amaurosis'' meaning ''darkening'', ''dark'', or ''obscure'') is a [[wikt:transience|transient]] [[Monocular vision|monocular visual]] loss (i.e., loss of vision in one eye that is not permanent).<ref name="fisher">{{cite journal |author=Fisher CM |title='Transient monocular blindness' versus 'amaurosis fugax' |journal=Neurology |volume=39 |issue=12 |pages=1622–4 |year=1989 |month=December |pmid=2685658 }}</ref>

==Pathophysiology and etiology==
Prior to 1990, amaurosis fugax could, "clinically, be divided into four identifiable symptom complexes, each with its underlying pathoetiology: embolic, hypoperfusion, angiospasm, and unknown".<ref name="Burde">{{cite journal |author=Burde RM |title=Amaurosis fugax. An overview |journal=J Clin Neuroophthalmol |volume=9 |issue=3 |pages=185–9 |year=1989 |month=September |pmid=2529279 }}</ref>  In 1990, the causes of amaurosis fugax were better refined by the Amaurosis Fugax Study Group, which has defined five distinct classes of transient monocular blindness based on their supposed cause: '''embolic, hemodynamic, ocular, neurologic''', and '''idiopathic''' (or "no cause identified") <ref name="ASG">{{cite journal |author= |title=Current management of amaurosis fugax. The Amaurosis Fugax Study Group |journal=Stroke |volume=21 |issue=2 |pages=201–8 |year=1990 |month=February |pmid=2406992 |url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=2406992 |doi= 10.1161/01.STR.21.2.201}}</ref> Concerning the pathology underlying these causes (except [[idiopathic]]), "some of the more frequent causes include atheromatous disease of the internal carotid or ophthalmic artery, vasospasm, optic neuropathies, giant cell arteritis, angle-closure glaucoma, increased intracranial pressure, orbital compressive disease, a steal phenomenon, and blood hyperviscosity or hypercoagulability."<ref name="Newman">{{cite book |author=Newman NJ. |chapter=Cerebrovascular disease |editor=Hoyt, William Graves; Miller, Neil; Newman, Nancy J.; Walsh, Frank |title=Walsh and Hoyt's Clinical Neuro-Ophthalmology |publisher=Williams & Wilkins |location=Baltimore |year=1998 |pages=3420–6 |isbn=0-683-30232-9 |volume=3 |edition=5th}}</ref>

===Embolic and hemodynamic origin===
With respect to embolic and hemodynamic causes, this transient monocular visual loss ultimately occurs due to a temporary reduction in [[retinal artery]], [[ophthalmic artery]], or [[Ciliary arteries|ciliary artery]] blood flow, leading to a decrease in retinal circulation which, in turn, causes retinal hypoxia.<ref name="vasospastic">{{cite journal |doi=10.1001/archopht.120.2.220 |author=Jehn A, Frank Dettwiler B, Fleischhauer J, Sturzenegger M, Mojon DS |title=Exercise-induced vasospastic amaurosis fugax |journal=Arch. Ophthalmol. |volume=120 |issue=2 |pages=220–2 |year=2002 |month=February |pmid=11831932 |url=http://archopht.ama-assn.org/cgi/content/extract/120/2/220}}</ref>  While, most commonly, emboli causing amaurosis fugax are described as coming from an atherosclerotic [[carotid artery]], any emboli arising from vasculature preceding the [[retinal artery]], [[ophthalmic artery]], or [[ciliary arteries]] may cause this transient monocular blindness.

*Atherosclerotic [[carotid artery]]: Amaurosis fugax may present as a type of [[transient ischemic attack]] (TIA), during which an [[Embolism|embolus]] unilaterally obstructs the lumen of the [[retinal artery]] or [[ophthalmic artery]], causing a decrease in blood flow to the ipsilateral retina.  The most common source of these athero-emboli is an atherosclerotic carotid artery.<ref name="braat">{{cite journal |author=Braat A, Hoogland PH, DeVries AC, de Mol VanOtterloo JCA |title=Amaurosis Fugax and Stenosis of the Ophthalmic Artery |journal=Vasc Endovascular Surg |volume=35 |issue=2 |pages=141–2 |year=2001 |doi=10.1177/153857440103500210 |url=http://ves.sagepub.com/cgi/content/abstract/35/2/141}}</ref><br>  However, a severely atherosclerotic [[carotid artery]] may also cause amaurosis fugax due to its [[stenosis]] of blood flow, leading to ischemia when the retina is exposed to bright light.<ref name="Kaiboriboon">{{cite journal |author=Kaiboriboon K, Piriyawat P, Selhorst JB |title=Light-induced amaurosis fugax |journal=Am. J. Ophthalmol. |volume=131 |issue=5 |pages=674–6 |year=2001 |month=May |pmid=11336956 |url=http://linkinghub.elsevier.com/retrieve/pii/S0002939400008746 |doi=10.1016/S0002-9394(00)00874-6}}</ref>  "Unilateral visual loss in bright light may indicate ipsilateral carotid artery occlusive disease and may reflect the inability of borderline circulation to sustain the increased retinal metabolic activity associated with exposure to bright light."<ref name="Furlan">{{cite journal |author=Furlan AJ, Whisnant JP, Kearns TP |title=Unilateral visual loss in bright light. An unusual symptom of carotid artery occlusive disease |journal=Arch. Neurol. |volume=36 |issue=11 |pages=675–6 |year=1979 |month=November |pmid=508123 |url=http://archneur.ama-assn.org/cgi/pmidlookup?view=long&pmid=508123}}</ref>

*Atherosclerotic [[ophthalmic artery]]: Will present similarly to an atherosclerotic internal carotid artery.

*Cardiac [[emboli]]: Thrombotic emboli arising from the heart may also cause luminal obstruction of the retinal, ophthalmic, and/or ciliary arteries, causing decreased blood flow to the ipsilateral retina; examples being those arising due to (1) atrial fibrillation, (2) valvular abnormalities including post-rheumatic valvular disease, mitral valve prolapse, and a bicuspid aortic valve, and (3) [[atrial myxoma]]s.

*Temporary [[vasospasm]] leading to decreased blood flow can be a cause of amaurosis fugax.<ref name="Fisher">{{cite journal |author=Fisher M |title=Transient monocular blindness associated with hemiplegia |journal=Arch Ophthalmol. |volume=47 |issue=2 |pages=167–203 |year=1952 | pmid = 14894017 }}</ref><ref name="Ellenberger">{{cite journal |author=Ellenberger C, Epstein AD |title=Ocular complications of atherosclerosis: what do they mean? |journal=Semin Neurol |volume=6 |issue=2 |pages=185–93 |year=1986 |month=June |pmid=3332423 |doi=10.1055/s-2008-1041462 }}</ref>  Generally, these episodes are brief, lasting no longer that five minutes,<ref name="stephen">{{cite journal |doi=10.1056/NEJM199109193251207 |author=Burger SK, Saul RF, Selhorst JB, Thurston SE |title=Transient monocular blindness caused by vasospasm |journal=N. Engl. J. Med. |volume=325 |issue=12 |pages=870–3 |year=1991 |month=September |pmid=1875972 }}</ref> and have been associated with exercise.<ref name="vasospastic" /><ref name="Imes">{{cite journal |author=Imes RK, Hoyt WF |title=Exercise-induced transient visual events in young healthy adults |journal=J Clin Neuroophthalmol |volume=9 |pages=178–80 |year=1989 |pmid=2529277 |issue=3 }}</ref>  These vasospastic episodes are not restricted to young and healthy individuals.   "Observations suggest that a systemic hemodynamic challenge provoke[s] the release of vasospastic substance in the rentinal vasculature of one eye."<ref name="stephen" />

*[[Giant cell arteritis]]: Giant cell arteritis can result in granulomatous inflammation within the central rentinal artery and posterior ciliary arteries of eye, resulting in partial or complete occlusion, leading to decreased blood flow manifesting as amaurosis fugax.  Commonly, amaurosis fugax caused by giant cell arteritis may be associated with jaw claudication and headache.  However, it is also not uncommon for these patients to have no other symptoms.<ref name="Hayreh2">{{cite journal |author=Hayreh SS, Podhajsky PA, Zimmerman B |title=Occult giant cell arteritis: ocular manifestations |journal=Am. J. Ophthalmol. |volume=125 |issue=4 |pages=521–6 |year=1998 |month=April |pmid=9559738 |doi=10.1016/S0002-9394(99)80193-7 }}</ref>  One comprehensive review found a two to nineteen percent incidence of amaurosis fugax among these patients.<ref name="goodman">{{cite journal |author=Goodman BW |title=Temporal arteritis |journal=Am. J. Med. |volume=67 |issue=5 |pages=839–52 |year=1979 |month=November |pmid=389046 |doi=10.1016/0002-9343(79)90744-7 }}</ref>

*[[Systemic lupus erythematosus]]<ref name="giorgi">{{cite journal |author=Giorgi D, David V, Afeltra A, Gabrieli CB |title=Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome |journal=Ocul. Immunol. Inflamm. |volume=9 |issue=1 |pages=49–57 |year=2001 |month=March |pmid=11262668 |doi=10.1076/ocii.9.1.49.3980 }}</ref><ref name="GoldD">{{cite journal |author=Gold D, Feiner L, Henkind P |title=Retinal arterial occlusive disease in systemic lupus erythematosus |journal=Arch. Ophthalmol. |volume=95 |issue=9 |pages=1580–5 |year=1977 |month=September |pmid=901267 |url=http://archopht.ama-assn.org/cgi/pmidlookup?view=long&pmid=901267}}</ref>

*[[Periarteritis nodosa]]<ref name="NewmanNM">{{cite journal |author=Newman NM, Hoyt WF, Spencer WH |title=Macula-sparing monocular blackouts. Clinical and pathologic investigations of intermittent choroidal vascular insufficiency in a case of periarteritis nodosa |journal=Arch. Ophthalmol. |volume=91 |issue=5 |pages=367–70 |year=1974 |month=May |pmid=4150748 |url=http://archopht.ama-assn.org/cgi/pmidlookup?view=long&pmid=4150748}}</ref>

*[[Eosinophilia|Eosinophilic]] [[vasculitis]]<ref name="Schwartz">{{cite journal |author=Schwartz ND, So YT, Hollander H, Allen S, Fye KH |title=Eosinophilic vasculitis leading to amaurosis fugax in a patient with acquired immunodeficiency syndrome |journal=Arch Intern Med. |volume=146 |pages=2059–60 |year=1986 |doi=10.1001/archinte.146.10.2059 |pmid=3767551 |issue=10 }}</ref>

*[[Hyperviscosity syndrome]]<ref name="Bacigalupi" />
**[[Polycythemia]]<ref name="Berdel">{{cite journal |author=Berdel WE, Theiss W, Fink U, Rastetter J |title=Peripheral arterial occlusion and amaurosis fugax as the first manifestation of polycythemia vera. A case report |journal=Blut |volume=48 |issue=3 |pages=177–80 |year=1984 |month=March |pmid=6697006 |doi=10.1007/BF00320341 }}</ref>

*[[Hypercoagulability]]<ref name="Mundall">{{cite journal |author=Mundall J, Quintero P, Von Kaulla KN, Harmon R, Austin J |title=Transient monocular blindness and increased platelet aggregability treated with aspirin. A case report |journal=Neurology |volume=22 |issue=3 |pages=280–5 |year=1972 |month=March |pmid=5062262 }}</ref>
**[[Protein C deficiency]]<ref name="smith_db">{{cite journal |author=Smith DB, Ens GE |title=Protein C deficiency: a cause of amaurosis fugax? |journal=J. Neurol. Neurosurg. Psychiatr. |volume=50 |issue=3 |pages=361–2 |year=1987 |month=March |pmid=3559620 |pmc=1031809 |url=http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=3559620 |doi=10.1136/jnnp.50.3.361}}</ref>
**[[Antiphospholipid antibodies]]<ref name="Digre">{{cite journal |author=Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varner MW, Baringer JR |title=Amaurosis fugax associated with antiphospholipid antibodies |journal=Ann. Neurol. |volume=25 |issue=3 |pages=228–32 |year=1989 |month=March |pmid=2729913 |doi=10.1002/ana.410250304 }}</ref>
***[[Anticardiolipin antibodies]]<ref name="DigreK" />
***[[Lupus anticoagulant]]<ref name="Landi">{{cite journal |author=Landi G, Calloni MV, Grazia Sabbadini M, Mannuccio Mannucci P, Candelise L |title=Recurrent ischemic attacks in two young adults with lupus anticoagulant |journal=Stroke |volume=14 |issue=3 |pages=377–9 |year=1983 |pmid=6419415 |url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=6419415 |doi=10.1161/01.STR.14.3.377}}</ref><ref name="Elias">{{cite journal |author=Elias M, Eldor A |title=Thromboembolism in patients with the 'lupus'-type circulating anticoagulant |journal=Arch. Intern. Med. |volume=144 |issue=3 |pages=510–5 |year=1984 |month=March |pmid=6367679 |url=http://archinte.ama-assn.org/cgi/pmidlookup?view=long&pmid=6367679 |doi=10.1001/archinte.144.3.510}}</ref>

*[[Thrombocytosis]]<ref name="DigreK" />

*[[Subclavian steal syndrome]]

*[[Malignant hypertension]] can cause ischemia of the optic nerve head leading to transient monocular visual loss.<ref name="HayrehSS">{{cite journal |author=Hayreh SS, Servais GE, Virdi PS |title=Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy |journal=Ophthalmology |volume=93 |issue=1 |pages=74–87 |year=1986 |month=January |pmid=3951818 }}</ref>

*Drug abuse-related intravascular emboli<ref name="ASG" />

*[[Iatrogenic]]: Amaurosis fugax can present as a complication following [[carotid endarterectomy]], carotid [[angiography]], [[cardiac catheterization]], and [[cardiac bypass]].<ref name="DigreK" />

===Ocular origin===
Ocular causes include:
*[[Iritis]]<ref name="Sorensen">{{cite journal |doi=10.1111/j.1755-3768.1983.tb04348.x |author=Sørensen PN |title=Amaurosis fugax. A unselected material |journal=Acta Ophthalmol (Copenh) |volume=61 |issue=4 |pages=583–8 |year=1983 |month=August |pmid=6637419 }}</ref>
*[[Keratitis]]<ref name="Bacigalupi">{{cite journal |author=Bacigalupi M |title=Amaurosis Fugax-A Clinical Review |journal=The Internet Journal of Allied Health Sciences and Practice |volume=4 |issue=2 |pages=1–6 |year=2006 |month=April  |url=http://ijahsp.nova.edu/articles/vol4num2/Bacigalupi.pdf}}</ref>
*[[Blepharitis]]<ref name="Bacigalupi" />
*[[Optic disc drusen]]<ref name="DigreK" />
*[[Posterior vitreous detachment]]<ref name="Bacigalupi" />
*[[glaucoma|Closed-angle glaucoma]]<ref name="Ravits">{{cite journal |author=Ravits J, Seybold ME |title=Transient monocular visual loss from narrow-angle glaucoma |journal=Arch. Neurol. |volume=41 |issue=9 |pages=991–3 |year=1984 |month=September |pmid=6477235 |url=http://archneur.ama-assn.org/cgi/pmidlookup?view=long&pmid=6477235}}</ref>
*Transient elevation of intraocular pressure<ref name="ASG" /><ref name="Sorensen" />
*Intraocular [[hemorrhage]]<ref name="ASG" />
*[[Coloboma]]<ref name="DigreK" />
*[[Myopia]]<ref name="DigreK" />
*Orbital [[hemangioma]]<ref name="BrownGC">{{cite journal |author=Brown GC, Shields JA |title=Amaurosis fugax secondary to presumed cavernous hemangioma of the orbit |journal=Ann Ophthalmol |volume=13 |issue=10 |pages=1205–9 |year=1981 |month=October |pmid=7316347 }}</ref>
*Orbital [[osteoma]]<ref name="WilkesSR">{{cite journal |author=Wilkes SR, Trautmann JC, DeSanto LW, Campbell RJ |title=Osteoma: an unusual cause of amaurosis fugax |journal=Mayo Clin. Proc. |volume=54 |issue=4 |pages=258–60 |year=1979 |month=April |pmid=423606 }}</ref>
*[[Keratoconjunctivitis sicca]]<ref name="DigreK" />

===Neurologic origin===
Neurological causes include:
*[[Optic neuritis]]<ref name="ASG" />

*Compressive [[optic neuropathy|optic neuropathies]]<ref name="ASG" /><ref name="DigreK">{{cite book |author=Corbett, James W.; Digre, Kathleen B. |title=Practical viewing of the optic disc |publisher=Butterworth-Heinemann |location=Oxford |year=2003 |pages=269–344 |isbn=0-7506-7289-7 |chapter=Amaurosis Fugax and Not So Fugax—Vascular Disorders of the Eye |chapterurl=http://intl.elsevierhealth.com/e-books/pdf/783.pdf }}</ref>

*[[Papilledema]]: "The underlying mechanism for visual obscurations in all of these patients appear to be transient ischemia of the optic nerve head consequent to increased tissue pressure. Axonal swelling, intraneural masses, and increased influx of [[interstitial fluid]] may all contribute to increases in tissue pressure in the optic nerve head. The consequent reduction in perfusion pressure renders the small, low-pressure vessels that supply the optic nerve head vulnerable to compromise. Brief fluctuations in intracranial or systemic blood pressure may then result in transient loss of function in the eyes."<ref name="Sadun">{{cite journal |author=Sadun AA, Currie JN, Lessell S |title=Transient visual obscurations with elevated optic discs |journal=Ann. Neurol. |volume=16 |issue=4 |pages=489–94 |year=1984 |month=October |pmid=6497356 |doi=10.1002/ana.410160410 }}</ref>  Generally, this transient visual loss is also associated with a headache and optic disk swelling.

*[[Multiple Sclerosis]] can cause amaurosis fugax due to a unilateral conduction block, which is a result of demyelination and inflammation of the optic nerve, and "...possibly by defects in synaptic transmission and putative circulating blocking factors."<ref name="Smith">{{cite journal |author=Smith KJ, McDonald WI |title=The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease |journal=Philos. Trans. R. Soc. Lond., B, Biol. Sci. |volume=354 |issue=1390 |pages=1649–73 |year=1999 |month=October |pmid=10603618 |pmc=1692682 |doi=10.1098/rstb.1999.0510 |url=http://rstb.royalsocietypublishing.org/cgi/pmidlookup?view=long&pmid=10603618}}</ref>

*[[Migraine]]<ref name="mattsson">{{cite journal |author=Mattsson, Lundberg |last2=Lundberg |first2=PO |title=Characteristics and prevalence of transient visual disturbances indicative of migraine visual aura |journal=Cephalalgia |volume=19 |issue=5 |year=1999 |month=June | pmid = 10403062 |pages=479–84 }}</ref><ref name="cologno">{{cite journal |author=Cologno D, Torelli P, Manzoni GC |title=Transient visual disturbances during migraine without aura attacks |journal=Headache |volume=42 |issue=9 |pages=930–3 |year=2002 |month=October |pmid=12390623 |url=http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0017-8748&date=2002&volume=42&issue=9&spage=930 |doi=10.1046/j.1526-4610.2002.02216.x}}</ref><ref name="ConnorRCR">{{cite journal |author=Connor RC |title=Complicated migraine. A study of permanent neurological and visual defects caused by migraine |journal=Lancet |volume=2 |issue=7265 |pages=1072–5 |year=1962 |month=November |pmid=14022628 }}</ref><ref name="CarrollD">{{cite journal |author=Carroll D |title=Retinal migraine |journal=Headache |volume=10 |issue=1 |pages=9–13 |year=1970 |month=April |pmid=5444866 |doi=10.1111/j.1526-4610.1970.hed1001009.x }}</ref><ref name="McDonaldWI">{{cite journal |author=McDonald WI, Sanders MD |title=Migraine complicated by ischaemic papillopathy |journal=Lancet |volume=2 |issue=7723 |pages=521–3 |year=1971 |month=September |pmid=4105666 }}</ref><ref name="WolterJR">{{cite journal |author=Wolter JR, Burchfield WJ |title=Ocular migraine in a young man resulting in unilateral transient blindness and retinal edema |journal=Pediatr Ophthalmol. |volume=8 |pages=173–6 |year=1971 }}</ref><ref name="KlineLB">{{cite journal |author=Kline LB, Kelly CL |title=Ocular migraine in a patient with cluster headaches |journal=Headache |volume=20 |issue=5 |pages=253–7 |year=1980 |month=September |pmid=7451120 |doi=10.1111/j.1526-4610.1980.hed2005253.x }}</ref><ref name="CorbettJJ">{{cite journal |author=Corbett JJ. |title=Neuro-ophthalmologic complications of migraine and cluster headaches |journal=Neurol Clin. |volume=1 |issue=4 |pages=973–95 |year=1983 | pmid = 6390159 }}</ref>

*[[Pseudotumor cerebri]]<ref name="HedgesT" />

*[[Intracranial tumor]]<ref name="HedgesT">{{cite journal |author=Hedges TR |title=The terminology of transient visual loss due to vascular insufficiency |journal=Stroke |volume=15 |issue=5 |pages=907–8 |year=1984 |pmid=6474546 |url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=6474546 |doi=10.1161/01.STR.15.5.907}}</ref>

*[[Psychogenic pain|Psychogenic]]<ref name="Bacigalupi" />

==Symptoms==
The experience of amaurosis fugax is classically described as a transient monocular vision loss that appears as a "[[curtain]] coming down vertically into the [[visual field|field of vision]] in one eye;" however, this altitudinal visual loss is relatively uncommon.  In one study, only 23.8 percent of patients with transient monocular vision loss experienced the classic "curtain" or "shade" descending over their vision.<ref name="noauthor">{{cite journal |doi= 10.1056/NEJM199108153250701 |author= |title=Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators |journal=N. Engl. J. Med. |volume=325 |issue=7 |pages=445–53 |year=1991 |month=August |pmid=1852179 }}</ref>  Other descriptions of this experience include a monocular blindness, dimming, fogging, or blurring.<ref name="Lord">{{cite journal |author=Lord RS |title=Transient monocular blindness |journal=Aust N Z J Ophthalmol |volume=18 |issue=3 |pages=299–305 |year=1990 |month=August |pmid=2261177 |doi=10.1111/j.1442-9071.1990.tb00624.x }}</ref>  Total or sectorial [[vision loss]] typically lasts only a few seconds, but may last minutes or even hours.  Duration depends on the etiology of the vision loss.  Obscured vision due to papilledema may last only seconds, while a severely atherosclerotic carotid artery may be associated with a duration of one to ten minutes.<ref name="Donders">{{cite journal |author=Donders RC, Dutch Tmb Study Group |title=Clinical features of transient monocular blindness and the likelihood of atherosclerotic lesions of the internal carotid artery |journal=J. Neurol. Neurosurg. Psychiatr. |volume=71 |issue=2 |pages=247–9 |year=2001 |month=August |pmid=11459904 |pmc=1737502 |url=http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=11459904 |doi=10.1136/jnnp.71.2.247 }}</ref>  Certainly, additional symptoms may be present with the amaurosis fugax, and those findings will depend on the etiology of the transient monocular vision loss.

==Diagnostic evaluation==
Despite the temporary nature of the vision loss, those experiencing amaurosis fugax are usually advised to consult a [[physician]] immediately as it is a [[symptom]] that usually heralds serious vascular events, including [[stroke]].<ref name="benavente">{{cite journal |author=Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJ, Meldrum H |title=Prognosis after transient monocular blindness associated with carotid-artery stenosis |journal=N. Engl. J. Med. |volume=345 |issue=15 |pages=1084–90 |year=2001 |month=October |pmid=11596587 |url=http://content.nejm.org/cgi/pmidlookup?view=short&pmid=11596587&promo=ONFLNS19 |doi=10.1056/NEJMoa002994}}</ref><ref name="rothwell">{{cite journal |author=Rothwell PM, Warlow CP |title=Timing of TIAs preceding stroke: time window for prevention is very short |journal=Neurology |volume=64 |issue=5 |pages=817–20 |year=2005 |month=March |pmid=15753415  |url=http://www.neurology.org/cgi/pmidlookup?view=long&pmid=15753415 |doi=10.1212/01.WNL.0000152985.32732.EE }}</ref>  Restated, “because of the brief interval between the transient event and a stroke or blindness from temporal arteritis, the workup for transient monocular blindness should be undertaken without delay.”  If the patient has no history of giant cell arteritis, the probability of vision preservation is high; however, the chance of a stroke reaches that for a hemispheric TIA.  Therefore, investigation of cardiac disease is justified.<ref name="ASG" />

A diagnostic evaluation should begin with the patient's history, followed by a physical exam, with particular importance being paid to the ophthalmic examination with regards to signs of ocular ischemia.  When investigating amaurosis fugax, an ophthalmologic consult is absolutely warranted if available.  Several concomitant laboratory tests should also be ordered to investigate some of the more common, systemic causes listed above, including a complete blood count, erythrocyte sedimentation rate, lipid panel, and blood glucose level.  If a particular etiology is suspected based on the history and physical, additional relevant labs should be ordered.<ref name="ASG" />

If laboratory tests are abnormal, a systemic disease process is likely, and, if the ophthalmologic examination is abnormal, ocular disease is likely.  However, in the event that both of these routes of investigation yield normal findings, or an inadequate explanation, noninvasive duplex ultrasound studies are recommended to identify carotid artery disease.  Most episodes of amaurosis fugax are the result of stenosis of the ipsilateral carotid artery.<ref name="smit">{{cite journal |author=Smit RL, Baarsma GS, Koudstaal PJ |title=The source of embolism in amaurosis fugax and retinal artery occlusion |journal=Int Ophthalmol |volume=18 |issue=2 |pages=83–6 |year=1994 |pmid=7814205 |url=http://www.iovs.org/cgi/reprint/1/1/136.pdf |doi=10.1007/BF00919244}}</ref>  With that being the case, researchers investigated how best to evaluate these episodes of vision loss, and concluded that for patients ranging from 36–74 years old, "...carotid artery duplex scanning should be performed...as this investigation is more likely to provide useful information than an extensive cardiac screening (ECG, Holter 24-hour monitoring and precordial echocardiography)."<ref name="smit"/>  Additionally, concomitant head CT or MRI imaging is also recommended to investigate the presence of a “clinically silent cerebral embolism.”<ref name="ASG" />

If the results of the ultrasound and intracranial imaging are normal, “renewed diagnostic efforts may be made,” during which [[fluorescein angiography]] is an appropriate consideration.  However, carotid angiography is not advisable in the presence of a normal ultrasound and CT.<ref name="walsh">{{cite journal |author=Walsh J, Markowitz I, Kerstein MD |title=Carotid endarterectomy for amaurosis fugax without angiography |journal=Am. J. Surg. |volume=152 |issue=2 |pages=172–4 |year=1986 |month=August |pmid=3526933 |url=http://linkinghub.elsevier.com/retrieve/pii/0002-9610(86)90236-9 |doi=10.1016/0002-9610(86)90236-9 |format=}} {{dead link|date=July 2010}}</ref>

==Treatment==
If the diagnostic workup reveals a systemic disease process, directed therapies to treat that underlying etiology should be initiated.  If the amaurosis fugax is caused by an atherosclerotic lesion, [[aspirin]] is indicated, and a [[carotid endarterectomy]] considered based on the location and grade of the stenosis.  Generally, if the carotid artery is still patent, the greater the stenosis, the greater the indication for endarterectomy.  "Amaurosis fugax appears to be a particularly favorable indication for carotid endarterectomy. Left untreated, this event carries a high risk of stroke; after carotid endarterectomy, which has a low operative risk, there is a very low postoperative stroke rate."<ref name="bernstein">{{cite journal |author=Bernstein EF, Dilley RB |title=Late results after carotid endarterectomy for amaurosis fugax |journal=J. Vasc. Surg. |volume=6 |issue=4 |pages=333–40 |year=1987 |month=October |pmid=3656582 |doi=10.1067/mva.1987.avs0060333 }}</ref> However, the rate of subsequent stroke after amaurosis is significantly less than after a hemispheric TIA, therefore there remains debate as to the precise indications for which a carotid endarterectomy should be performed. If the full diagnostic workup is completely normal, patient observation is recommended.<ref name="ASG" />
* [http://www.health32.com/amaurosis-fugax-treatment/ Amaurosis fugax: Treatment]

==See also==
*[[Ocular ischemic syndrome]]
*[[Amaurosis]]

==References==
{{reflist|2}}

{{Diseases of the nervous system}}
{{Eye pathology}}

[[Category:Stroke]]
[[Category:Diseases of the eye and adnexa]]
[[Category:Episodic and paroxysmal disorders]]
[[Category:Symptoms]]